We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Gastric Inhibitory Polypeptide (GIP) Antibodies|
|Epitope||AA 44-85 Alternatives|
|Reactivity||Mouse (Murine) Alternatives|
|Conjugate||This GIP antibody is un-conjugated Alternatives|
Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-GIP AntibodyTarget Details GIP Application Details Handling Images
|Purpose||Rabbit IgG polyclonal antibody for Gastric inhibitory polypeptide(GIP) detection. Tested with WB in Mouse.|
|Cross-Reactivity (Details)||No cross reactivity with other proteins.|
Rabbit IgG polyclonal antibody for Gastric inhibitory polypeptide(GIP) detection. Tested with WB in Mouse.
Gene Name: gastric inhibitory polypeptide
Protein Name: Gastric inhibitory polypeptide
|Purification||Immunogen affinity purified.|
|Immunogen||E. coli-derived mouse GIP recombinant protein (Position: Y44-Q85). Mouse GIP shares 92.9% amino acid (aa) sequence identity with both human and rat GIP.|
|Plasmids, Primers & others|
Target Details GIPProduct Details anti-GIP Antibody Application Details Handling Images back to top
|Alternative Name||GIP (GIP Antibody Abstract)|
Gastric inhibitory polypeptide (GIP), also known as the glucose-dependent insulinotropic peptide, is an inhibiting hormone of the secretin family of hormones. GIP is thought to have significant effects on fatty acid metabolism through stimulation of lipoprotein lipase activity in adipocytes. Additionally, GIP release has been demonstrated in the ruminant animal and may play a role in nutrient partitioning in milk production (lipid metabolism). Recently, GIP appeared as a major player in bone remodelling. It was evidenced that genetic ablation of the GIP receptor in mice resulted in profound alterations of bone microarchitecture through modification of the adipokine network. Furthermore, the deficiency in GIP receptors has also been associated in mice with a dramatic decrease in bone quality and a subsequent increase in fracture risk.
Synonyms: Gastric Inhibitory Peptide | GIP | P48756
|Pathways||Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism|
Application DetailsProduct Details anti-GIP Antibody Target Details GIP Handling Images back to top
WB: Concentration: 0.1-0.5 μg/mL, Tested Species: Mouse
Notes: Tested Species: Species with positive results.
Other applications have not been tested. Optimal dilutions should be determined by end users.
Antibody can be supported by chemiluminescence kit ABIN921124 in WB.
|Restrictions||For Research Use only|
HandlingProduct Details anti-GIP Antibody Target Details GIP Application Details Images back to top
|Reconstitution||Add 0.2 mL of distilled water will yield a concentration of 500 μg/mL.|
|Buffer||Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Sodium azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
At -20°C for one year. After reconstitution, at 4°C for one month.
It can also be aliquotted and stored frozen at -20 °C for a longer time. Avoid repeated freezing and thawing.
ImagesProduct Details anti-GIP Antibody Target Details GIP Application Details Handling back to top